Page last updated: 2024-10-25

desipramine and Atrioventricular Nodal Re-Entrant Tachycardia

desipramine has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 2 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, XJ1
Cox, HS1
Dart, AM1
Esler, MD1
Peters, RW1
Buser, GA1
Kim, HJ1
Gold, MR1

Other Studies

2 other studies available for desipramine and Atrioventricular Nodal Re-Entrant Tachycardia

ArticleYear
Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure.
    Cardiovascular research, 1999, Volume: 43, Issue:4

    Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Atenolol;

1999
Tricyclic overdose causing sustained monomorphic ventricular tachycardia.
    The American journal of cardiology, 1992, Nov-01, Volume: 70, Issue:13

    Topics: Adult; Desipramine; Drug Overdose; Electrocardiography; Humans; Male; Tachycardia, Ventricular

1992